Albuterol is used to prevent and treat lung illnesses such asthma and chronic obstructive pulmonary disease that cause breathing problems, wheezing, shortness of breath, coughing, and chest tightness. To avoid breathing problems when exercising, albuterol inhalation aerosol and powder for oral inhalation are also used.
Adults and kids aged 4 and older can take albuterol inhalation aerosol. Children 12 years of age and older utilise oral albuterol inhalation powder. Adults and kids 2 years old and older utilise albuterol solution for oral inhalation. The drug albuterol belongs to the group of drugs known as bronchodilators.
To facilitate breathing, it relaxes and widens airways in the lungs. Albuterol is available as an aerosol or powder to take by mouth using an inhaler as well as a solution to use with a special jet nebulizer equipment that transforms medicine into a mist that can be inhaled.
The inhalation aerosol or powder for oral inhalation is typically administered every 4 to 6 hours as needed to treat or prevent lung disease symptoms. It is customary to use the inhalation aerosol or powder for oral inhalation 15 to 30 minutes prior to exercise to prevent respiratory difficulties while exercising.
Typically, three to four times a day are used to use the nebulizer solution. Ask your doctor or chemist to explain any instructions on your prescription label that you are unsure about following.Implement albuterol precisely as advised. Use it only as directed by your doctor, neither more nor less often.
Depending on its size, each albuterol aerosol inhaler is intended to deliver 60 or 200 inhalations. The capacity of each albuterol powder inhaler is 200 breaths. Further inhalations could not contain the prescribed dosage of medication if the labelled number of inhalations has been reached.
Even if the aerosol inhaler still has some liquid inside and continues to spray when the button is pressed after you have used the prescribed number of inhalations, discard it.
After the expiration date on the container, 13 months after you open the foil wrapper, or after you’ve used the recommended number of inhalations, whichever comes first, dispose of the powder inhaler.
The Global Albuterol Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
ProAir RespiClick Inhalation Powder was introduced by Teva Pharmaceutical Industries Ltd. to treat or prevent bronchospasm in children 4 to 11 years old with reversible obstructive airway disease and to prevent exercise-induced bronchospasm.
The FDA reviewed data from Teva’s Phase III clinical trial programme that assessed the safety and efficacy of the medication in kids as young as four years old who had asthma before approving ProAir RespiClick for use in children.
The information showed that, as compared to a placebo, ProAir RespiClick medication significantly improved forced expiratory volume. Upper respiratory infections, throat and mouth pain, and vomiting were the most frequent adverse reactions to ProAir RespiClick therapy.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.